Harlan Robins's most recent trade in Adaptive Biotechnologies Corp was a trade of 284,800 Common Stock done at an average price of $6.6 . Disclosure was reported to the exchange on July 21, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 21 Jul 2026 | 284,800 | 1,304,458 (1%) | 0% | 6.6 | 1,865,440 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | 21 Jul 2026 | 284,800 | 0 | - | - | Stock Option (right to buy) | ||
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 21.72 per share. | 21 Jul 2026 | 278,698 | 1,025,760 (0%) | 0% | 21.7 | 6,053,321 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 22.12 per share. | 21 Jul 2026 | 213,702 | 812,058 (0%) | 0% | 22.1 | 4,727,088 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 21.74 per share. | 02 Jul 2026 | 239,351 | 1,166,547 (0%) | 0% | 21.7 | 5,203,491 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 22.45 per share. | 02 Jul 2026 | 146,889 | 1,019,658 (0%) | 0% | 22.4 | 3,297,658 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 17.37 per share. | 15 Jun 2026 | 100,000 | 1,412,058 (1%) | 0% | 17.4 | 1,737,000 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.01 per share. | 15 Jun 2026 | 6,160 | 1,405,898 (1%) | 0% | 18.0 | 110,942 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.85 per share. | 08 Apr 2026 | 10,000 | 1,512,058 (1%) | 0% | 14.9 | 148,500 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.85 per share. | 08 Apr 2026 | 10,000 | 1,512,058 (1%) | 0% | 14.9 | 148,500 | - |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.17 per share. | 11 Mar 2026 | 329,600 | 1,522,058 (1%) | 0% | 13.2 | 4,340,832 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.17 per share. | 11 Mar 2026 | 329,600 | 1,522,058 (1%) | 0% | 13.2 | 4,340,832 | - |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.17 per share. | 11 Mar 2026 | 140,666 | 1,851,658 (1%) | 0% | 13.2 | 1,852,571 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 13.17 per share. | 11 Mar 2026 | 140,666 | 1,851,658 (1%) | 0% | 13.2 | 1,852,571 | - |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 709,220 | 1,992,324 (1%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 709,220 | 1,992,324 (1%) | 0% | 0 | - | |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 127,813 | 1,283,104 (1%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2026 | 127,813 | 1,283,104 (1%) | 0% | 0 | - | |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.52 per share. | 02 Mar 2026 | 14,233 | 1,155,291 (0%) | 0% | 16.5 | 235,129 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.52 per share. | 02 Mar 2026 | 14,233 | 1,155,291 (0%) | 0% | 16.5 | 235,129 | - |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.72 per share. | 02 Mar 2026 | 10,000 | 1,169,524 (0%) | 0% | 15.7 | 157,200 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 15.72 per share. | 02 Mar 2026 | 10,000 | 1,169,524 (0%) | 0% | 15.7 | 157,200 | - |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.60 per share. | 02 Feb 2026 | 34,668 | 1,187,644 (0%) | 0% | 18.6 | 644,825 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.60 per share. | 02 Feb 2026 | 34,668 | 1,187,644 (0%) | 0% | 18.6 | 644,825 | - |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 02 Feb 2026 | 8,120 | 1,179,524 (0%) | 0% | 19 | 154,280 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 19.00 per share. | 02 Feb 2026 | 8,120 | 1,179,524 (0%) | 0% | 19 | 154,280 | - |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.44 per share. | 06 Jan 2026 | 10,000 | 1,222,312 (0%) | 0% | 16.4 | 164,400 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.44 per share. | 06 Jan 2026 | 10,000 | 1,222,312 (0%) | 0% | 16.4 | 164,400 | - |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.61 per share. | 03 Dec 2025 | 27,212 | 1,242,312 (0%) | 0% | 18.6 | 506,415 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 18.61 per share. | 03 Dec 2025 | 27,212 | 1,242,312 (0%) | 0% | 18.6 | 506,415 | - |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.61 per share. | 03 Dec 2025 | 10,000 | 1,232,312 (0%) | 0% | 16.6 | 166,100 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 16.61 per share. | 03 Dec 2025 | 10,000 | 1,232,312 (0%) | 0% | 16.6 | 166,100 | - |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.82 per share. | 10 Nov 2025 | 10,000 | 1,269,524 (1%) | 0% | 14.8 | 148,200 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 14.82 per share. | 10 Nov 2025 | 10,000 | 1,269,524 (1%) | 0% | 14.8 | 148,200 | - |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | 01 May 2025 | 68,412 | 0 | - | - | Stock Option (Right to Buy) | ||
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.35 per share. | 01 May 2025 | 68,412 | 1,279,524 (1%) | 0% | 7.3 | 502,828 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 01 May 2025 | 68,412 | 1,347,936 (1%) | 0% | 6.3 | 432,364 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 01 May 2025 | 68,412 | 1,347,936 (1%) | 0% | 6.3 | 432,364 | - |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 7.35 per share. | 01 May 2025 | 68,412 | 1,279,524 (1%) | 0% | 7.3 | 502,828 | - |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 24 Mar 2025 | 1,698 | 1,281,222 (1%) | 0% | 6.3 | 10,731 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 24 Mar 2025 | 1,698 | 1,279,524 (1%) | 0% | 9 | 15,282 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | 24 Mar 2025 | 1,698 | 68,412 | - | - | Stock Option (Right to Buy) | ||
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.32 per share. | 24 Mar 2025 | 1,698 | 1,281,222 (1%) | 0% | 6.3 | 10,731 | - |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 24 Mar 2025 | 1,698 | 1,279,524 (1%) | 0% | 9 | 15,282 | - |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 355,000 | 1,376,180 (1%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2025 | 355,000 | 1,376,180 (1%) | 0% | 0 | - | |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.99 per share. | 04 Mar 2025 | 56,053 | 1,279,524 (1%) | 0% | 7.0 | 391,810 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.99 per share. | 04 Mar 2025 | 56,053 | 1,279,524 (1%) | 0% | 7.0 | 391,810 | - |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.98 per share. | 04 Mar 2025 | 40,603 | 1,335,577 (1%) | 0% | 7.0 | 283,409 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 6.98 per share. | 04 Mar 2025 | 40,603 | 1,335,577 (1%) | 0% | 7.0 | 283,409 | - |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 354,610 | 1,021,180 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2023 | 354,610 | 666,570 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | 04 Mar 2022 | 617,792 | 617,792 | - | - | Stock Option (Right to Buy) | ||
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 247,117 | 316,477 (0%) | 0% | 0 | Common Stock | |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 04 Mar 2022 | 4,517 | 311,960 (0%) | 0% | 12.0 | 54,249 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 32.05 per share. | 17 Nov 2021 | 3,700 | 69,360 (0%) | 0% | 32.1 | 118,585 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | 17 Nov 2021 | 3,700 | 285,100 | - | - | Stock Option (Right to Buy) | ||
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 17 Nov 2021 | 3,700 | 73,060 (0%) | 0% | 6.6 | 24,235 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | 17 Nov 2021 | 300 | 284,800 | - | - | Stock Option (Right to Buy) | ||
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Sale of securities on an exchange or to another person at price $ 31.36 per share. | 17 Nov 2021 | 300 | 69,360 (0%) | 0% | 31.4 | 9,408 | Common Stock |
| Adaptive biotech Corp | Dr. Harlan Robins, PhD | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.55 per share. | 17 Nov 2021 | 300 | 69,660 (0%) | 0% | 6.6 | 1,965 | Common Stock |